Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01808846 · ClinicalTrials.gov registry record
Neural Functioning of Feeding Centers in Obese Youth
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 51
- Enrollment target
NCT01808846: Completed study, sponsored by Yale University.
NCT01808846 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01808846 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
To explore whether obese adolescents with insulin resistance and relative low leptin levels exhibit functional alterations of the neuronal circuits involved in the regulation of energy metabolism and food seeking behaviors. We here propose to test the hypothesis that the reward circuitry is dysregulated in obese adolescents and is related to the degree of insulin resistance and hyperinsulinemia.
Primary Outcome
fmri on 3T to measure blood flow response after ingestion of glucose drink
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2010-07 |
| Est. Completion | 2017-02 |
What the finished NCT01808846 record still lists
NCT01808846 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01808846 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01808846 about?
NCT01808846 is a clinical study titled "Neural Functioning of Feeding Centers in Obese Youth". To explore whether obese adolescents with insulin resistance and relative low leptin levels exhibit functional alterations of the neuronal circuits involved in the regulation of energy metabolism and food seeking behaviors. We here propose to test the hypothesis that the reward circuitry is dysregu...
What is the current status of trial NCT01808846?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2010-07. Estimated completion is 2017-02.
Who is sponsoring clinical trial NCT01808846?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia